<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Developing Rabies Monoclonal Antibody Products as a Component of Rabies Post-Exposure Prophylaxis; Public Workshop; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Developing Rabies Monoclonal Antibody Products as a Component of Rabies Post-Exposure Prophylaxis; Public Workshop; Request for Comments</h1>
    <p class="timestamp">Published: 2017-06-07 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, the Agency, or we) is announcing a public workshop regarding development of rabies monoclonal antibody products to be used in conjunction with licensed rabies vaccine as part of a rabies post-exposure prophylaxis (PEP) regimen. This public workshop is intended to provide information for, and gain perspective from, health care providers, other U.S. Government Agencies, academic experts, industry, and other stakeholders on various aspects of development effor...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-11820</p>
    <p><strong>Publication Date:</strong> 2017-06-07</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/06/07/2017-11820/developing-rabies-monoclonal-antibody-products-as-a-component-of-rabies-post-exposure-prophylaxis">https://www.federalregister.gov/documents/2017/06/07/2017-11820/developing-rabies-monoclonal-antibody-products-as-a-component-of-rabies-post-exposure-prophylaxis</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-11820</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
